ClinicalTrials.gg
RecruitingNCT06337500LABLifeUpdated Jul 18, 2025

Validation of a Making Decision Hybrid (Ecologic and Virtual) Task

An interventional study of Neurophysiological measure (EEG) and Survey in Healthy Volunteers and Behavior and Behavior Mechanisms, sponsored by Centre Hospitalier Universitaire de Besancon. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-18.

Sponsored by Centre Hospitalier Universitaire de Besancon · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 69 studies in Behavior with a site in France — 15 open to participants now, 15 under way, none of them phase 3. Behavior · France.

Planned enrollment
10th of 47
180 · median 100
Started
2024
the only one that year
No phase
45 of 69
14 open now
Primary completion
2026-02
later than 6 of 14 live
Registered
60th of 69
by date

Among the 69 studies in Behavior with a site in France, this one is the 10th largest by planned enrollment of the 47 interventional ones that give a count, is the only one that started in 2024, is one of 45 with no phase, reaches primary completion later than 6 of the 14 other live ones, and was the 60th registered.

Behavior

1,579 studies on the registry are indexed under Behavior; 314 are open to participants now.

Browse Behavior studies →

Open to participants now

15 of the 69 studies in Behavior with a site in France are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 177 Behavior studies recruiting now, 77 (44%) set no upper age limit and 72 (41%) stop at 75 or younger; 58 take children under 18; 99 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Behavior with a site in France, or all of them as a file.
02

Study summary

The aim of this study is to validate a new hybrid (ecological + virtual) decision-making tool. The difference in behavior (risky choices) between the "hybrid" task and the "virtual" task will be evaluated.

03

Conditions studied

  • Healthy Volunteers
  • Behavior and Behavior Mechanisms

Browse trials for

Keywords

  • decision-making
  • ecological task
  • brain activity
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women aged 18 to 65 inclusive
  • Subjects with no neurological or psychiatric disorders
  • Subjects with no addictive disorder except tobacco
  • Signed indicating that the subject has understood the purpose and procedures of the study and agrees to participate in the study and to abide by the requirements and restrictions inherent in the study
  • Affiliation with a French social security scheme or beneficiary of such a scheme.

Exclusion criteria

Exclusion Criteria:

  • Men and women under 18 or over 65 years of age
  • Subjects suffering from a neurological or psychiatric disorder
  • Subjects suffering from an addictive disorder, with the exception of tobacco
  • Legal incapacity or limited legal capacity
  • Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
  • Subject without health insurance
  • Pregnant
  • Subject within the exclusion period of another study or on the "national volunteer list".
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Iowa Gambling Task - ecologic

    The participant performs the card selection task in its ecological version (with real cards).

    Other: Survey

  • Active comparator
    Iowa Gambling Task - virtual

    The participant performs the card selection task in its virtual version (computer task).

    Device: Neurophysiological measure (EEG) · Other: Survey

  • Experimental
    Iowa Gambling Task - hybrid

    The participant performs the card selection task thanks to our homemade interface "LAB-Life".

    Device: Neurophysiological measure (EEG) · Other: Survey

  • Experimental
    Game of Dice Task - ecologic

    The participant performs the dice-rolling task in its ecological version (with real dices).

    Other: Survey

  • Active comparator
    Game of Dice Task - virtual

    The participant performs the dice-rolling task in its virtual version (computer task)

    Device: Neurophysiological measure (EEG) · Other: Survey

  • Experimental
    Game of Dice Task - hybrid

    The participant performs the dice-rolling task thanks to our homemade interface "LAB-Life".

    Device: Neurophysiological measure (EEG) · Other: Survey

Interventions

  • DeviceNeurophysiological measure (EEG)

    Cerebral electric activity recorded with EEG

  • OtherSurvey

    Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

06

What researchers measure

Primary outcomes

  1. Validation of the homemade "Lab-Life" interface as a tool for simulating an ecological task with sufficient fidelity, while meeting the conditions required for recording high-quality brain activity using an EEG-HR.

    Behavioral score obtained after completion of the hybrid task (netscore obtained at the IGT). This score can be compared with the scores obtained after the ecological and virtual tasks.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Feb 2026, 24 months after the start.

Of 745 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 24 months is above that.

Counting every sponsor, half of 761 studies reached it within 13 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 15, 2024
First posted
Mar 29, 2024
StartActual
Feb 1, 2024
Primary completionEst.
Feb 1, 2026
CompletionEst.
Jun 1, 2026
Last update
Jul 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06337500
Responsible party
Sponsor
First posted
Mar 29, 2024
Start date
Feb 1, 2024
Primary completion
Feb 1, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
Jul 18, 2025

Study contacts

Karine CHARRIERE, PhD
Contact
kcharriere@chu-besancon.fr
+333 81218999
Julie GIUSTINIANI, MD
principal investigator · CHU Besançon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion